Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

seekingalpha.com - Wall Street Week Ahead - Apple Leads Packed Earnings Calendar As Investors Eye Tech, Pharma Results
Apple Leads Packed Earnings Calendar As Investors Eye Tech, Pharma Results
Seeking Alpha –

Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs…

econotimes.com - Helena Ward - Sun Pharma Q2 Profit Falls 36.2% as Adjusted Net Profit Rises
Sun Pharma Q2 Profit Falls 36.2% as Adjusted Net Profit Rises
EconoTimes –

Sun Pharmaceutical Industries reported a 36.2% year-over-year drop in second-quarter net profit after exceptional costs, even as revenue and adjusted profit rose, leaving growth uneven across its major markets. Sun Pharma's unaudited results put…

marketbeat.com - Spyglass Pharma (NASDAQ:SGP) Upgraded to 'Hold' at Wall Street Zen
Spyglass Pharma (NASDAQ:SGP) Upgraded to 'Hold' at Wall Street Zen
MarketBeat –

Spyglass Pharma (NASDAQ:SGP - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a research note issued to investors on Saturday, Wall Street Zen reports. SGP has been the subject of…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Stock Price Target Cut by TD Cowen
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Target Cut by TD Cowen
MarketBeat –

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price objective lowered by analysts at TD Cowen from $110.00 to $100.00 in a report issued on Friday, Benzinga reports. The firm presently has a 'buy' rating on the stock. TD Cowen 's target…

marketbeat.com - Ascendis Pharma A/S (NASDAQ:ASND) Stock Rating Cut to 'Hold' at Wall Street Zen
Ascendis Pharma A/S (NASDAQ:ASND) Stock Rating Cut to 'Hold' at Wall Street Zen
MarketBeat –

Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a 'buy' rating to a 'hold' rating in a report released on Saturday, Wall Street Zen reports. Can BioMarin Stock Live Up to Wall…

marketbeat.com - OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Stock Short Interest Report for October
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Stock Short Interest Report for October
MarketBeat –

OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 76,652 shares, a growth of 121.3% from the September 30th total of…

fool.com - Motley Fool Transcribing - Aptar (ATR) Q3 2026 Earnings Call Transcript
Aptar (ATR) Q3 2026 Earnings Call Transcript
The Motley Fool –

Senior Vice President, Investor Relations and Communications - Mary Skafidas President and CEO - Gael Touya Executive Vice President and CFO - Vanessa Kanu Reported Sales -- $1.02 billion, representing a 6% increase driven by broad-based growth…

newsweek.com - Andrew Stanton - Maine's Fragile Healthcare System is Under Duress: How Collins, Jackson Will Approach It
Maine's Fragile Healthcare System is Under Duress: How Collins, Jackson Will Approach It
Newsweek –

Incumbent Susan Collins and Troy Jackson face a tight race for U.S. Senate in Maine as the state's healthcare system is under duress ahead of Tuesday's midterm elections. Healthcare has become a major dividing line between Collins, a moderate…

news-medical.net - Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai
Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai
News-Medical –

Dr. Jue Wang, Head of Global Business Development at Insilico Medicine, has been invited to attend the China Healthcare Summit in Shanghai. On the afternoon of November 3 at 16:45, she will deliver a keynote speech in the panel titled: 'THE…

businessinsider.com - Tom Carter - Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
Business Insider –

In a cavernous office in London's AI hub, a group of researchers is preparing to do battle with humanity's oldest enemy. Isomorphic Labs, a spinoff of Google DeepMind and the brainchild of AI pioneer Demis Hassabis, has an ambitious mission even by…

businessinsider.com - Stephen Council - Anthropic's next big AI business is life sciences, from biotech research to drug discovery
Anthropic's next big AI business is life sciences, from biotech research to drug discovery
Business Insider –

Anthropic conquered coding. Now it's setting its sights on the human body. Anthropic's S-1 filing, which outlines its ambitions and financials ahead of a massive initial public offering next month, reads as a life-sciences manifesto. The maker of…

ndtv.com - Abhinav Singh - Indian Biotech Startup Claims To Offer Personalised Cancer Vaccines
Indian Biotech Startup Claims To Offer Personalised Cancer Vaccines
NDTV –

PopVax launches RNA Foundry to develop personalised cancer vaccines using mRNA technology. Summary is AI-generated, newsroom-reviewed PopVax launched RNA Foundry to develop personalised cancer vaccines in Hyderabad The facility uses mRNA technology…

econotimes.com - Celia Rowan - ACE Equity Screen Cited by ETMarkets.com Puts Laurus Labs Up 21%
ACE Equity Screen Cited by ETMarkets.com Puts Laurus Labs Up 21%
EconoTimes –

An ACE Equity screen cited by ETMarkets.com placed Laurus Labs first among eight stocks in India's BSE 500 index with reported five-session gains, showing a 21% rise over the period ending Oct. 30. ETMarkets.com said roughly 18 companies in the…

fool.com - Keith Speights - 2 Stocks Billionaires Can't Stop Buying
2 Stocks Billionaires Can't Stop Buying
The Motley Fool –

If you've seen one billionaire investor's portfolio... you've seen one billionaire investor's portfolio. The super-wealthy don't always see eye to eye on where to put their money. However, that's not always the case. Here are two stocks that…

pakobserver.net - Web Desk Lahore - A look at Top Stocks at PSX as Market ends October 2026 in Red
A look at Top Stocks at PSX as Market ends October 2026 in Red
Pakistan Observer –

KARACHI – Pakistan Stock Exchange (PSX) wrapped up October 2026 under pressure, with investors witnessing turbulent trading session as the benchmark KSE-100 Index lost 784 points on Friday, October 30, wiping out part of the gains…

Receive a Daily briefing on Pharma Industry News

Get Started